VAERS reports by lot

GSK Varicella/Shingles lot 4ME42: VAERS reports

33 VAERS reports list lot 4ME42 as a GSK Varicella/Shingles vaccine, received between 2020-01-20 and 2021-01-14. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
6%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4031%
Cardiac / Cardiovascular2015%
Injection-site / Local reaction1915%
Neurological1612%
Dermatological (non-injection-site)129%
Musculoskeletal97%
Allergic / Anaphylactic75%
Thrombotic / Hematological32%
Respiratory22%
Gastrointestinal22%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 11).

New York7
Pennsylvania7
Michigan6
Florida4
Ohio2
California1
North Carolina1
Texas1
Georgia1
Virginia1
Minnesota1

Reports by month received

2020-012
2020-025
2020-034
2020-044
2020-051
2020-065
2020-071
2020-083
2020-091
2020-102
2020-111
2020-122
2021-012

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.